Product
Cetuximab-IRDye800
4 clinical trials
9 indications
Indication
lung cancerIndication
Video-assisted Thoracic SurgeryIndication
EGFRIndication
CetuximabIndication
Head and Neck CancerIndication
Head and Neck Squamous Cell CarcinomaIndication
Rectal CancerIndication
GlioblastomaIndication
high-grade gliomaClinical trial
Study Protocol for Near-infrared Molecular Imaging for Lung Cancer Detection and Treatment During Mini-invasive Surgery (Phase II Trial) - (the RECOGNISE Study)Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Real-time Margin Assessment in Head and Neck Cancer - Enhancing Specificity by Combining Fresh Frozen Sectioning With Targeted Fluorescence ImagingStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery of Locally Advanced Rectal Cancer Using Cetuximab-IRDye800CW: a Single-center Feasibility and Safety StudyStatus: Completed, Estimated PCD: 2022-01-28
Clinical trial
Multispectral and Bimodal Fluorescent Guided Surgery (FGS) of High-grade Glioma for Refining Margin Assessment: A Phase 1 Dose Finding Study Using Cetuximab-IRDye800CW Combined With 5-ALA.Status: Recruiting, Estimated PCD: 2024-10-01